Kanabo Group (KNB) Share Price, News & Analysis

Company Overview

Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain. It also provides cultivation consultancy for cannabis businesses, as well as develops and distributes cannabis derived medicinal and wellness products. Kanabo Group Plc was incorporated in 2016 and is based in London, the United Kingdom.

Key Stats

• Today's Range: 0.80 to 1
• 50-Day Range: 0.80 to 1.20
• 52-Week Range: 0.80 to 3.20
• Volume: 475,837 shs
• Average Volume: 428,867 shs
• Market Capitalization: £5.06 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KNB Stock Analysis - Frequently Asked Questions

How have KNB shares performed this year?

Kanabo Group's stock was trading at GBX 2.80 at the start of the year. Since then, KNB stock has decreased by 71.4% and is now trading at GBX 0.80.
View the best growth stocks for 2024 here.

How do I buy shares of Kanabo Group?

Shares of KNB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Kanabo Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Kanabo Group investors own include BP (BP), Entain (ENT), Lloyds Banking Group (LLOY), Legal & General Group (LGEN), Meta Platforms (META), Piedmont Lithium (PLL) and Alliance Pharma (APH).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: N/A
• Current Symbol: LON:KNB
• CUSIP: N/A
• CIK: N/A
• Web: www.kanabogroup.com
• Phone: N/A
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-8,180,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -83.19%
• Return on Assets: -20.89%

Debt

• Debt-to-Equity Ratio: 3.49
• Current Ratio: 2.78
• Quick Ratio: 24.36

Sales & Book Value

• Annual Sales: £1.14 million
• Price / Sales: 4.44
• Cash Flow: GBX 0.44 per share
• Price / Cash Flow: 1.82
• Book Value: GBX 1 per share
• Price / Book: 0.80

Miscellaneous

• Outstanding Shares: 632,430,000
• Free Float: N/A
• Market Cap: £5.06 million
• Optionable: Not Optionable
• Beta: 3.04